| Literature DB >> 25058678 |
Zhenming Yu1, Kajia Cao1, Tanya Tischler1, Catherine A Stolle1, Avni B Santani2.
Abstract
Targeted DNA enrichment coupled with next generation sequencing has been increasingly used for interrogation of select sub-genomic regions at high depth of coverage in a cost effective manner. Specificity measured by on-target efficiency is a key performance metric for target enrichment. Non-specific capture leads to off-target reads, resulting in waste of sequencing throughput on irrelevant regions. Microdroplet-PCR allows simultaneous amplification of up to thousands of regions in the genome and is among the most commonly used strategies for target enrichment. Here we show that carryover of single-stranded template genomic DNA from microdroplet-PCR constitutes a major contributing factor for off-target reads in the resultant libraries. Moreover, treatment of microdroplet-PCR enrichment products with a nuclease specific to single-stranded DNA alleviates off-target load and improves enrichment specificity. We propose that nuclease treatment of enrichment products should be incorporated in the workflow of targeted sequencing using microdroplet-PCR for target capture. These findings may have a broad impact on other PCR based applications for which removal of template DNA is beneficial.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25058678 PMCID: PMC4110027 DOI: 10.1371/journal.pone.0103491
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
On-target efficiency for libraries prepared from untreated RainDance captured DNA.
| Sample ID | Total reads | Aligned reads | Reads on target | On-target efficiency |
|
| 2193674 | 1888037 | 609182 | 32.3% |
|
| 2002723 | 1747191 | 598175 | 34.2% |
|
| 4516825 | 4245272 | 674674 | 15.9% |
Figure 1Mung bean nuclease treatment abolished the high molecular DNA smear in RainDance captured DNA after end repair.
A. An overview of the workflow. Aliquots of 100ng of DNA enriched through microdroplet-PCR were either treated with mung-bean nuclease or untreated as a control. The differentially treated aliquots were end-repaired, concatenated, processed into TruSeq libraries and sequenced on MiSeq in parallel to rule out any batch effect. B. Electrophoresis analysis of DNA samples on a high-sensitivity DNA chip using the Agilent 2100 Bioanalyzer. DNA samples in all 4 lanes were derived from 200pg of the same batch of captured DNA. From left to right, the lanes are, “L” lane-the DNA size ladder, lane 1-untreated DNA enriched by RainDance microdroplet-PCR prior to end repair, lane 2- untreated DNA enriched by RainDance microdroplet-PCR post end repair, lane 3- mung bean nuclease treated DNA enriched by RainDance microdroplet-PCR prior to end repair, lane 4- mung bean nuclease treated DNA enriched by RainDance microdroplet-PCR post end repair.
On-target efficiency for libraries prepared from samples either treated or untreated with the mung bean nuclease.
| Sample ID | Nuclease treatment | Total reads | Aligned reads | Reads on target | On-target efficiency | Fold increase |
|
| No | 2040068 | 1888854 | 513149 | 27.2% | 2.19 |
| Yes | 2176298 | 1798070 | 1069568 | 59.5% | ||
|
| No | 2344430 | 2158492 | 603053 | 27.9% | 2.09 |
| Yes | 1847463 | 1499265 | 877131 | 58.5% | ||
|
| No | 4185191 | 3917002 | 759764 | 19.4% | 3.84 |
| Yes | 3360424 | 2907096 | 2164377 | 74.5% |
Figure 2Mung bean nuclease treatment significantly increases on-target efficiency for DNA enriched through RainDance microdroplet-PCR.
Aliquots of RainDance enriched DNA for the same sample were either treated or not treated with mung bean nuclease, processed into TruSeq libraries, and sequenced on MiSeq as illustrated in Figure 1A. Plotted is the mean value of on-target efficiency of 3 samples that went through parallel treatments (also see Table 2). Nuclease treatment leads to significantly higher on-target efficiency (*p = 0.018, one-tail paired t test; error bar, SEM).
Comparison of variants detected for the same sample either treated or not treated with mung bean nuclease.
| Sample ID | Nuclease Treatment | Index | Chr. Position | Gene | Coverage | Score | Mutation Call | Amino Acid Change |
|
| Not treated | 1 | 2∶39294787 | SOS1 | 983 | 23.9 | T>GT | 65R>RR |
| 2 | 7∶140449150 | BRAF | 4274 | 28.1 | T>CT | 643G>GG | ||
| 3 | 11∶534242 | HRAS | 1668 | 23.9 | A>AG | 27H>HH | ||
| 4 | 11∶119145667 | CBL | 2011 | 23.4 | A>AG | |||
| 5 | 11∶119170362 | CBL | 1395 | 24 | C>CT | 864L>LL | ||
| 6 | 12∶25362777 | KRAS | 1247 | 22.9 | A>AG | |||
| 7 | 19∶4110552 | MAP2K2 | 130 | 14 | C>CG | 135G>GG | ||
| 8 | 19∶4117528 | MAP2K2 | 1219 | 22.4 | G>AG | 64V>VV | ||
| Treated | 1 | 2∶39294787 | SOS1 | 2322 | 24.4 | T>GT | 65R>RR | |
| 2 | 7∶140449150 | BRAF | 7266 | 30 | T>CT | 643G>GG | ||
| 3 | 11∶534242 | HRAS | 2615 | 27.2 | A>AG | 27H>HH | ||
| 4 | 11∶119145667 | CBL | 5181 | 26 | A>AG | |||
| 5 | 11∶119170362 | CBL | 2569 | 27.2 | C>CT | 864L>LL | ||
| 6 | 12∶25362777 | KRAS | 4268 | 28.9 | A>AG | |||
| 7 | 12∶25368462 | KRAS | 4 | 1.2 | C>T | 161R>R | ||
| 8 | 19∶4110552 | MAP2K2 | 258 | 17.4 | C>CG | 135G>GG | ||
| 9 | 19∶4117528 | MAP2K2 | 2531 | 26.6 | G>AG | 64V>VV | ||
|
| Not treated | 1 | 2∶39249915 | SOS1 | 938 | 23.3 | T>CT | 552R>GR |
| 2 | 2∶39294787 | SOS1 | 1163 | 24.5 | T>GT | 65R>RR | ||
| 3 | 11∶534242 | HRAS | 1788 | 25.5 | A>G | 27H>H | ||
| 4 | 12∶25362777 | KRAS | 1560 | 25.4 | A>AG | |||
| 5 | 19∶4101062 | MAP2K2 | 3810 | 28.3 | G>GT | 220I>II | ||
| Treated | 1 | 2∶39249915 | SOS1 | 2607 | 24.4 | T>CT | 552R>GR | |
| 2 | 2∶39294787 | SOS1 | 2253 | 24.9 | T>GT | 65R>RR | ||
| 3 | 11∶534242 | HRAS | 1240 | 24 | A>G | 27H>H | ||
| 4 | 12∶25362777 | KRAS | 3890 | 28.6 | A>AG | |||
| 5 | 12∶25368462 | KRAS | 8 | 7.2 | C>T | 161R>R | ||
| 6 | 19∶4101062 | MAP2K2 | 2139 | 25.2 | G>GT | 220I>II | ||
|
| Not treated | 1 | 11∶534242 | HRAS | 294 | 19.6 | A>AG | 27H>HH |
| 2 | 12∶25368462 | KRAS | 21 | 10.3 | C>T | 161R>R | ||
| 3 | 15∶66782048 | MAP2K1 | 1502 | 25.3 | C>CT | |||
| Treated | 1 | 11∶534242 | HRAS | 807 | 20.6 | A>AG | 27H>HH | |
| 2 | 12∶25368462 | KRAS | 67 | 14.3 | C>T | 161R>R | ||
| 3 | 15∶66782048 | MAP2K1 | 5411 | 27.7 | C>CT |
*: Variants detected only when samples were treated with mung bean nuclease.